Nephrogenic systemic fibrosis

Dec 03, 2019

Artificial intelligence software confirms the results of a large scale comparison of ProHance® (Gadoteridol) Injection, 279.3 mg/mL and Gadavist® (gadobutrol) Injection in MRI of the brain (the TRUTH study)

Nov 26, 2018

Guerbet To Showcase Innovative Diagnostic and Interventional Imaging Solutions at RSNA 2018

Oct 24, 2018

IQ-AI Files Patent for Contrast-Free Imaging

Dec 27, 2017

Gadolinium-based contrast agents: update from Guerbet LLC on U.S. Food and Drug Administration (FDA) requirements

Dec 21, 2017

Global Gadolinium Market 2017-2023 - Growing Demand for Medical Equipment will Boost the Market

Sep 08, 2017

Guerbet Statement Following FDA Medical Imaging Drugs Advisory Committee September 8, 2017

Sep 05, 2017

FDA Approves Guerbet's Dotarem® (gadoterate meglumine) for Pediatric Patients Younger Than Two Years